Asia Pacific Pharmaceutical: Announcement on not revising the debt-to-equity conversion price of AsiaPharma Pharmaceuticals

SZSI · Dec 22, 2022 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.